There are no new drugs for motor neuron disease in the clinic, but for example, riluzole and edaravone can treat motor neuron disease.
Riluzole has the effect of inhibiting the release of glutamate, which can improve neurons and slow down the progress of motor neuron disease. Note that the drug has adverse effects on the digestive system, and regular monitoring of liver and kidney function is required during administration. The drug is contraindicated for those who are allergic to riluzole, those with abnormal liver function, and women who are pregnant or breastfeeding.
Edaravone has the effect of scavenging free radicals and improving neurons, and is often used to treat acute attacks of cerebral infarction. Rash, abdominal distension, fever and other symptoms may occur when taking this drug. Note that it is prohibited for those who are allergic to edaravone, those with severe renal failure, pregnant and lactating women, and children.
In recent years, although there have been reports of the above two drugs being used in the treatment of motor neuron disease to slow down the progression of the patient’s condition and improve the quality of life, the improvement of their symptoms is not obvious.
It is recommended that patients with motor neuron disease should adopt a good dietary habit while receiving medication, focusing on increasing nutrition and strengthening physical fitness, and avoiding smoking and alcohol. If there is any fluctuation of the disease, consult the doctor in time.